Accounting Value per Share: Dentsply (XRAY)

XRAY (Dentsply Sirona Inc) - company brandmark

The daily price action for DENTSPLY SIRONA Inc. (XRAY), a manufacturer of dental devices, is currently at 6.83. A stable workforce of R&D engineers and software developers guarantees technological progress. However, geopolitical tensions and a shortage of microchips from Asia are impacting earnings. Revenue is also subject to moderate fluctuations, as people undergo expensive aesthetic procedures less frequently during recessionary periods.

XRAY Dentsply Sirona Inc Accounting Value per Share (07/04/2022 - 10/29/2026)

Financial and market metric breakdowns for dentsplysirona.com (XRAY)

- stock price and consensus target price:
Stock Price Dentsply|XRAY - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Valuation DENTSPLY SIRONA Inc.|XRAY - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Dentsply Sirona|XRAY - Company Net Assets|Market Capitalization to Book Value Ratio dentsplysirona.com|XRAY - Company Assets
- debt and liquidity details:
Total Debt to Capital DENTSPLY SIRONA Inc.|XRAY - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Dentsply Sirona|XRAY - Company Total Debt Obligations|Debts to Book Capitalization DENTSPLY SIRONA Inc.|XRAY - Company Long-Term Liabilities|Company Short-Term Debts Dentsply Sirona|Quick Liquidity dentsplysirona.com
- earnings and multiples data:
XRAY - Company Net Income
Fundamental company analysis:Dentsply (XRAY)
Manufactured products of dentsplysirona.com

Book value per share determines the portion of equity attributable to a single security after deducting all liabilities. The trend in net book value per share reflects the capitalization efficiency of DENTSPLY SIRONA Inc. (XRAY) innovations within the dental sector. Premium pricing on equipment directly increases the volume of net assets. Steady growth in this metric confirms the fundamental resilience of the business, while a decline signals a systemic impairment of resources.

Competitor analysis

Intuitive Surgical Inc - Book Value per Share|DHR - Book Value per Share|BDX (Becton Dickinson & Co) - Accounting Value per Share|Net Asset Value per Share steris.com (STE)|Net Assets per Single Share West Pharmaceutical Services, Inc.|Accounting Value per Share Baxter International Inc. (BAX)|Book Value per Share MASI|STVN - Net Asset Value per Share|Book Value per Share TFX (Teleflex Incorporated)|MMSI: Equity per Share|Envista - Book Value per Share|Net Assets per Share ICU Medical Inc ICUI|LMAT: Book Value per Share|Accounting Value per Share AtriCure Medical|STAA (STAAR Surgical Company) - Book Value per Share|Book Value per Share Niagen|Net Assets per Single Share ZimVie (ZIMV)|Net Assets per Single Share ANGO (AngioDynamics Inc)|Cerus Corp - Accounting Value per Share|Accounting Value of a Share TKNO|Monogram Technologies - Book Value per Share|Net Assets per Share Sharps Technology, Inc. STSS|infusystem.com (INFU) - Net Assets per Single Share|Equity per Share UTMD|Net Assets per Single Share KORU Medical Systems, Inc.|Nyxoah S.A (NYXH) - Net Assets per Share|Accounting Value per Share MBOT (Microbot Medical Inc.)|Book Price of a Share PDEX|Net Assets per Single Share Zentek ZTEK|Accounting Value of a Share ELUT|MLSS: Accounting Value per Share|NXGL - Book Value per Share|retractable.com (RVP) - Net Assets per Single Share|Accounting Value per Share harvardbioscience.com|FEMY (Femasys) - Book Value per Share|Net Asset Value per Share Meihua Medical MHUA|Net Assets per Single Share Predictive Oncology (POAI)|callanjmb.com - Equity per Share|Atrion Corporation - Accounting Value per Share|Book Price of a Share NURO (neurometrix.com)